
Biocon Limited has informed the Exchange regarding a press release dated October 06, 2023, titled "Biocon Limited signs commercialization agreement with Juno Pharmaceuticals in Canada".
Filed with NSE ·

Biocon Limited has informed the Exchange regarding a press release dated October 06, 2023, titled "Biocon Limited signs commercialization agreement with Juno Pharmaceuticals in Canada".
6ix hasn’t read this filing yet.
Follow Biocon into a list and get an email when it puts out news.
Follow Biocon